28 related articles for article (PubMed ID: 12239445)
1. Low-cost outpatient chemotherapy regimen of cisplatin, 5-fluorouracil and leucovorin for advanced head and neck and esophageal carcinomas.
Fabrício Vde C; Amado F; Del Giglio A
Sao Paulo Med J; 2008 Jan; 126(1):63-6. PubMed ID: 18425290
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study.
Gural Z; Saglam S; Yucel S; Kaytan-Saglam E; Asoglu O; Ordu C; Acun H; Sharifov R; Onder S; Kizir A; Oral EN
World J Gastrointest Oncol; 2018 Jan; 10(1):40-47. PubMed ID: 29375747
[TBL] [Abstract][Full Text] [Related]
3. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
Erjala K; Raitanen M; Kulmala J; Grénman R
J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904
[TBL] [Abstract][Full Text] [Related]
4. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).
Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J
Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
Anticancer Res; 2001; 21(6A):4135-9. PubMed ID: 11911307
[TBL] [Abstract][Full Text] [Related]
7. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.
Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E
Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396
[TBL] [Abstract][Full Text] [Related]
9. Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer.
Orecchia R; Jereczek-Fossa BA; Catalano G; Chiesa F; De Pas T; Masci G; Krengli M; Vavassori A; De Paoli F; Robertson C; Marrocco E; De Braud F
Oncology; 2002; 63(2):115-23. PubMed ID: 12239445
[TBL] [Abstract][Full Text] [Related]
10. Current role of chemotherapy in head and neck cancer.
Tobias JS
Drugs; 1992 Mar; 43(3):333-45. PubMed ID: 1374318
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials with fluorinated pyrimidines in patients with head and neck cancer.
al-Sarraf M
Invest New Drugs; 1989 Apr; 7(1):71-81. PubMed ID: 2661485
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic management of head and neck cancer.
Al-Sarraf M
Cancer Metastasis Rev; 1987; 6(3):181-98. PubMed ID: 3319271
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
